Mergers & Acquisitions - Biotechnology


Current filters:


Popular Filters

226 to 249 of 249 results

RusNano to start production of vaccines and organogels


Russia’s RusNano (Russian Corporation of Nanotechnologies) has signed an agreement with Russian…

Anti-viralsBiotechnologyCardio-vascularEpidbiomedEuropeFinancialMarkets & MarketingMergers & AcquisitionsNanolekOncologyRusNanoVaccines

Smith & Nephew to spin-out biologics and clinical therapies unit


Texas, USA-based venture capital firm Essex Woodlands has entered into a strategic partnership with the…

BiotechnologyBioventusMergers & AcquisitionsSmith & Nephew

Biotech predictions for 2012 from sector specialist Steven Burrill


As 2011 drew to a close, Steven Burrill, chief executive of global life sciences financial services firm…

BiotechnologyFinancialMergers & AcquisitionsNorth AmericaPharmaceuticalRegulation

Actelion pulls out of Trophos option


Switzerland-based Actelion (SIX: ATLN), Europe’s biggest biotech company, says that it has decided…

ActelionBiotechnologyLicensingMergers & AcquisitionsolesoximePharmaceuticalRare diseasesTrophos

US Biotech scores wins in November, despite global economic turmoil, says Burrill


Economic and political worries in Europe and the USA fuelled another month of wild gyrations in the stock…

BiotechnologyFinancialMergers & AcquisitionsNorth AmericaResearch

Gilead expands hepatitis C R&D portfolio with $11 billion buy of Pharmasset


In its biggest M&D deal to date, Gilead Sciences (Nasdaq: GILD) says it has signed a definitive agreement…

Anti-viralsBiotechnologyGilead SciencesMergers & AcquisitionsmericitabinePharmaceuticalPharmasset

Valeant to acquire Australia’s iNova for up to $946 million


Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (NYSE: VRX and TSX: VRX) has signed…

BiotechnologyiNovaMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals

Angiotech opts out of cardiovascular cell therapy program with Athersys


Regenerative medicines firm Athersys (Nasdaq: ATHX) says that Canada’s Angiotech Pharmaceuticals…

AngiotechAthersysBiotechnologyFinancialLicensingMergers & Acquisitions

Karo Bio to spin off preclinical development


In order to achieve better allocation of resources and competences, Swedish biotech firm Karo Bio (STO:…

BiotechnologyKaro BioMergers & AcquisitionsResearch

WuXi PharmaTech acquires China-based clinical services companies; ShangPharma buys Charles River research facility


WuXi PharmaTech (NYSE: WX) says it has acquired MedKey Med-Tech Development and Jiecheng Med-Tech Development,…

BiotechnologyCharles River LaboratoriesMergers & AcquisitionsPharmaceuticalShangPharmaWuXi Apptec

GlaxoSmithKline may be ready to acquire Human Genome, newspaper reports


Shares of the UK’s biggest pharmaceuticals group, GlaxoSmithKline (LSE: GSK) amid revived speculation…

BenlystaBiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Angel Biotech proposes joint venture with Russia’s Materia Medica


Scotland-based Angel Biotechnology (ABH: LON) saw its shares leap 20% to 0.28 pence on Monday after it…

Angel BiotechnologyBiotechnologyEuropeMateria MedicaMergers & Acquisitions

Benefits of Biotie’s 45 million-euro buy of Newron assessed by Edison Research


Finland-based Biotie Therapies’ (OMX: BTH1V) proposed c 45 million-euro all-stock merger with Italian…

BiotechnologyBiotie TherapiesMergers & AcquisitionsNeurologicalNewron PharmaPharmaceuticalResearch

US biotech sector besieged by debt worries, political dysfunction in 3rd-qtr, says Burrill


The fight in the USA over the raising of the debt ceiling and the debt crisis in Europe have fueled turmoil…

BiotechnologyFinancialMergers & AcquisitionsNorth AmericaRegulation

Contract research firm PPD to go private in $3.9 billion acquisition


USA-based contact research organization Pharmaceutical Product Development (Nasdaq: PPDI) says it has…

BiotechnologyMergers & AcquisitionsPharmaceuticalPPD

Biotie to buy Newron for 45 million euros, creating a European leader in CNS drug development


In a second acquisition this year, Finland-based biotech company Biotie Therapies (OMX: BTH1V) has entered…

BiotechnologyBiotie TherapiesMergers & AcquisitionsNeurologicalNewron PharmaPharmaceutical

VBI Vaccines acquires Epixis and its innovative eVLP vaccine platform


USA-based, privately-held biotechnology company VBI Vaccines said yesterday that it has completed the…

BiotechnologyEpixisMergers & AcquisitionsVaccinesVBI Vaccines

GlaxoSmithKline gets 25% stake in spin-out firm Autifony


UK pharma giant GlaxoSmithKline (LSE: GSK) has invested £1.25 million ($2.1 million) to receive a…

Autifony TherapeuticsBiotechnologyFinancialGlaxoSmithKlineMergers & Acquisitions

Proteon Thera gets new funding of $15 million, ahead of Novartis acquisition option


US privately-held biopharmaceutical firm Proteon Therapeutics, the subject of a takeover option by Swiss…

BiotechnologyFinancialMergers & AcquisitionsNovartisPharmaceuticalProteon TherapeuticsResearch

Rusnano and partners set up SynBio innovative pharmaceuticals project in Russia


Russia’s Human Stem Cells Institute, Rusnano (Russian Corporation of Nanotechnologies), Pharmsynthez,…

BiotechnologyFinancialLipoxenMergers & AcquisitionsRusNanoSymbioTecSynBio

AMAG Pharma and Allos Thera to merge in $686 million stock deal; Express Scripts to buy Medco


US drugmakers AMAG Pharmaceuticals (Nasdaq: AMAG) and Allos Therapeutics (Nasdaq: ALTH) entered into…

Allos TherapeuticsAMAG PharmaceuticalsBiotechnologyMergers & AcquisitionsPharmaceutical

226 to 249 of 249 results

Back to top